Moderna Requests Emergency Use Authorization for COVID-19 Bivalent Vaccine
Moderna filed with the FDA for emergency use authorization of a 50-µg dose of a BA.4./BA.5 Omicron-targeting bivalent booster vaccine for those aged ≥18 years.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 23, 2022
Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
New Novo Nordisk Combination Rx Better than Components for T2D, Weight Loss
Phase II clinical trial shows a fixed dose combination of semaglutide/cagrilintide reduces HbA1c and weight much better than either drug alone.
Vegetarian Diet May Up Risk for Hip Fracture in Women
Among more than 26 000 women, a vegetarian diet was associated with a 33% greater risk of hip fracture vs diets that included fish or meat.
Seen in the ED: Diarrhea and BUQ Pain
The woman is in her mid-fifties, diarrhea has been persistent for 10 days and BUQ pain for 2 days. What does the CT show? What's your diagnosis?
US Vaccine Fatigue May Harbor Some Unrealistic Expectations
Vaccine fatigue in the US, says Vanderbilt University's William Schaffner, MD, is plentiful for vaccines that are are good—but not perfect.
Pfizer-BioNTech Request EUA for Bivalent COVID-19 Vaccine for Fall
Pfizer-BioNTech filed with the FDA for emergency use authorization of a 30-mcg dose of an Omicron BA.4.BA.5-adapted vaccine for those aged ≥12 years.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 22, 2022
HHS: Monkeypox Vaccine Production to Begin in the US as Cases Surpass 14 000
Federal officials have announced an agreement between Jynneos manufacturer Bavarian Nordic and a Michigan-based drug maker to "fill and finish" US-owned doses.
Don't Call them "Boosters" Anymore and Other COVID-19 Vaccine Recommendations
Let's call the next round of COVID-19 shots "updated vaccines," and help the public understand the true role of this vaccination, says NFID's Schaffner.
New Real-world Study Finds Average Length of COVID-19 Infectiousness is 5 Days
A new real-world study found that two-thirds of patients with COVID-19 were still infectious 5 days and one-fourth at 7 days after symptom onset.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 19, 2022
William Schaffner, MD: "If It's Not Flu and It's Not COVID, It's Probably RSV"
Respiratory virus season is top of mind for Schaffner, medical director of the National Foundation for Infectious Diseases, and he says it's going to be a challenge.
COVID-19 Vaccine Risk Presented in Context Could Improve Uptake
Pair the risk of side effects associated with a COVID-19 shot with the risk of death in a car accident and see what happens. It worked in this study.
Gout Found More Prevalent among Black Adults in Nationally-representative Population
Racial disparities in gout prevalence could be explained by diet, social determinants of health, kidney disease, and other factors that suggest interventions.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 18, 2022
Persistent Vaccine Skepticism Can Erode Clinician Confidence in their Own Recommendations
Vaccine hesitancy and actual refusal can wear on clinicians over time; family physician Gretchen LaSalle, MD, offers potential antidotes to the frustration.
CDC Director Announces Broad Agency Restructuring Following External Review
The CDC's COVID-19 pandemic response was cited as a key factor driving plans to increase the agency's responsiveness and accountability.
Study Underscores Deficits in Management of COPD in Primary Care
Findings highlight the need for more real-life studies to support decision making within primary care settings, say researchers.
"Vaccination is More of a Marathon than a Sprint, so Keep Listening”
Listening to patient concerns about vaccines and guiding them to factual sources for answers pays off, says family physician Gretchen LaSalle, MD.